Evidence map›Paper›PMID 42456022›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2026

Adverse Birth Outcomes Associated With SARS-CoV-2 Infection Among Pregnant Women With and Without HIV: A Longitudinal Cohort Study.

Ibrahim Ahmed El-Imam, Abra Rachida Koudjra, Nginache Nampota-Nkomba, Felix Mkandawire, Osward Nyirenda, Rhoda Masonga, Cristiana Cairo, Melissa Gladstone, Miriam K Laufer, Andrea G Buchwald

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Ibrahim Ahmed El-ImamDepartment of Epidemiology and Public Health, University of Maryland, Baltimore, MD.
Abra Rachida KoudjraCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD.
Nginache Nampota-NkombaDepartment of Epidemiology and Public Health, University of Maryland, Baltimore, MD.
Felix MkandawireBlantyre Malaria Project, Kamuzu University of Health Sciences & University of Liverpool, Liverpool, United Kingdom.
Osward NyirendaBlantyre Malaria Project, Kamuzu University of Health Sciences & University of Liverpool, Liverpool, United Kingdom.
Rhoda MasongaBlantyre Malaria Project, Kamuzu University of Health Sciences & University of Liverpool, Liverpool, United Kingdom.
Cristiana CairoDepartment of Epidemiology and Public Health, University of Maryland, Baltimore, MD.
Melissa GladstoneUniversity of Liverpool, Liverpool, United Kingdom; and.
Miriam K LauferCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD.
Andrea G BuchwaldCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD.ORCID 0000-0001-6503-6459

Funding

Neurocognitive development of HIV-exposed and uninfected infants in MalawiR01HD100235 · NICHD · UNIVERSITY OF MARYLAND BALTIMORE · PI GLADSTONE, MELISSA, LAUFER, MIRIAM K. · 2020 to 2024
$3.3M
The impact of in utero HIV exposure on infant T and B cell responses in MalawiU01HD092308 · NICHD · UNIVERSITY OF MARYLAND BALTIMORE · PI CAIRO, CRISTIANA, LAUFER, MIRIAM K. · 2017 to 2021
$2.7M
Long-term neurocognitive outcomes of HIV-exposed uninfected childrenR33HD103066 · NICHD · UNIVERSITY OF MARYLAND BALTIMORE · PI GLADSTONE, MELISSA, LAUFER, MIRIAM K. · 2022 to 2024
$2.4M
Cross-disciplinary approach to understanding the long-term impact of HIV exposure in childrenR01HD119968 · NICHD · UNIVERSITY OF MARYLAND BALTIMORE · PI Arox Wadson Kamng'ona, Matthew Brent Laurens · 2025 to 2026
$1.2M
Dissecting the causal impact of prenatal HIV exposure and the postnatal environment on development in Malawian InfantsK01MH134741 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI BUCHWALD, ANDREA G. · 2023 to 2025
$468k
Eunice Kennedy Shriver National Institute of Child Health and Human Development R01HD100235Eunice Kennedy Shriver National Institute of Child Health and Human Development R33HD103066Eunice Kennedy Shriver National Institute of Child Health and Human Development U01HD092308NICHD NIH HHS R01 HD100235NICHD NIH HHS R01 HD119968NICHD NIH HHS R33 HD103066NICHD NIH HHS U01 HD092308NIMH NIH HHS K01 MH134741NIMH NIH HHS K01MH134741
6 · The paper itself

Abstract

backgroundCOVID-19 and HIV infection are independently associated with increased risk of adverse pregnancy outcomes. However, there is limited evidence on the effect of SARS-CoV-2 infection during pregnancy in sub-Saharan Africa, particularly among women living with HIV (WLWH).

settingTwo antenatal clinics in southern Malawi (2018-2022).

methodsWe conducted a prospective cohort study of singleton pregnancies enrolled at 20-36 weeks gestation. SARS-CoV-2 infection was determined through serologic testing at enrollment and delivery. Participants were enrolled based on HIV status and viral suppression: (1) WLWH with detectable viral load (VL), (2) WLWH with undetectable VL, and (3) HIV-negative women. We used a multivariable logistic regression with adjustment for confounding to evaluate the effect of SARS-CoV-2 alone or in combination with HIV infection on the following adverse birth outcomes: low birth weight (LBW), preterm birth, small-for-gestational-age (SGA), and stillbirth or early neonatal death.

resultsAmong 905 pregnant women, 29% tested positive for SARS-CoV-2, 87% of infections were mild or asymptomatic. Overall, SARS-CoV-2 infection was significantly associated with SGA births (adjusted OR [aOR]: 1.49, 95% CI: 1.03 to 2.13) but not associated with other adverse outcomes. Among WLWH, SARS-CoV-2 was significantly associated with increased odds of LBW (aOR: 2.07, 1.10 to 3.91) and SGA births (aOR: 1.73, 1.01 to 2.91). The effect of SARS-CoV-2 infection among WLWH did not differ based on VL.

conclusionsSARS-CoV-2 infection during pregnancy was associated with adverse birth outcomes, particularly among WLWH. These findings underscore the need for integrated antenatal care and targeted infection prevention strategies for pregnant women with HIV in high-burden settings.

Indexed as

COVID-19HIV InfectionsPregnancy Complications, InfectiousPregnancy OutcomeAdultFemaleHumansInfant, Low Birth WeightInfant, NewbornInfant, Small for Gestational AgeLongitudinal StudiesMalawiPregnancyPremature BirthProspective StudiesSARS-CoV-2HIVlow birth weightpregnancypregnancy outcomesSARS-CoV-2small for gestational age

Identifiers

PMID42456022
PMCPMC13686639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.